Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 1.825% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. O=C(N[C@@H](Cc1ccccc1)C(=O)NC1CC1)c1ccc(Cl)cc1
b. C=CCC1CCCCC12NC(=O)N(c1ccccc1)N2
c. COc1ccccc1CN(Cc1nc2ccccc2c(=O)[nH]1)C(=O)Nc1cccc(C)c1
Answer: a. O=C(N[C@@H](Cc1ccccc1)C(=O)NC1CC1)c1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(N[C@@H](Cc1ccccc1)C(=O)NC1CC1)c1ccc(Cl)cc1
O=C(N[C@@H](Cc1ccccc1)C(=O)NC1CC1)c1ccc(Cl)cc1
4-chloro-N-[(2S)-1-(cyclopropylamino)-1-oxo-3-phenylpropan-2-yl]benzamide